Long-term follow-up of a patient with eruptive melanocytic nevi after stevens-Johnson syndrome

Archives of Dermatology

Volumn 143, Issue 12, 2007, Pages 1555-1557

  Gelfer, Allison ^a   Rivers, Jason K ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Pacific Dermaesthetics   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOPSY; CASE REPORT; COMPARATIVE STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; MALE; MEDICAL LITERATURE; NEVUS; PRIORITY JOURNAL; RASH; RISK ASSESSMENT; STEVENS JOHNSON SYNDROME; VESICULAR RASH;

CHILD; HUMANS; LONGITUDINAL STUDIES; MALE; MELANOCYTES; NEVUS, PIGMENTED; STEVENS-JOHNSON SYNDROME;

EID: 37249028301     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.12.1555     Document Type: Article

References (29)

1. MacKie RM, English J, Aitchison T, Fitzsimons C, Wilson P. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol. 1985;113(2):167-174.
2. Hutchinson J. Outbreak of a large crop of pigmented moles: remarks as to possible connection with melanosis. J Cutan Med Dis Skin. 1868:170-171.
3. Soltani K, Bernstein J, Lorinez A. Eruptive nevocytic nevi following erythema multiforme. J Am Acad Dermatol. 1979;1(6):503-505.
4. Kirby JD, Darley C. Eruptive melanocytic naevi following severe bullous disease. Br J Dermatol. 1978;99(5):575-580.
5. Kopf AW, Grupper C, Baer R, Mitchell J. Eruptive nevocytic nevi after severe bullous disease. Arch Dermatol. 1977;113(8):1080-1084.
6. Shoji T, Cockerell C, Koff A, Bhawan J. Eruptive melanocytic nevi after Stevens-Johnson syndrome. J Am Acad Dermatol. 1997;37(2 pt 2):337-339.
7. Goerz G. Eruptive nevocytic nevi after Lyell's syndrome. Arch Dermatol. 1978;114(9):1400-1401.
8. Bauer JW, Schaeppi H, Kaserer C, Hantich B, Hintner H. Large melanocytic nevi in hereditary epidermolysis bullosa. J Am Acad Dermatol. 2001;44(4):577-584.
9. Lanschuetzer CM, Emberger M, Hametner R, et al. Pathogenic mechanisms in epidermolysis bullosa naevi. Acta Derm Venereol. 2003;83(5):332-337.
10. Firooz A, Komeili A, Dowlati Y. Eruptive melanocytic nevi and cherry angiomas secondary to exposure to sulfur mustard gas. J Am Acad Dermatol. 1999;40(4):646-647.
11. Betlloch I, Amador C, Chiner E, Pasquau F, Calpe J, Vilar A. Eruptive melanocytic nevi in human immunodeficiency virus infection. Int J Dermatol. 1991;30(4):303.
12. Duvic M, Lowe L, Rapini R, Rodriguez S, Levy M. Eruptive dysplastic nevi associated with human immunodeficiency virus infection. Arch Dermatol. 1989;125(3):397-401.
13. Richert S, Bloom E, Flynn K, Seraly M. Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myelocytic leukemia: case report and review of the literature. J Am Acad Dermatol. 1996;35(2 pt 2):326-329.
14. Hollenbeak CS, Todd M, Billingsley E, Harper G, Dyer A, Lengerich E. Increased incidence of melanoma in renal transplantation recipients. Cancer. 2005;104(9):1962-1967.
15. Piaserico S, Alaibac M, Fortina A, Peserico A. Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy. J Am Acad Dermatol. 2006;54(2):338-340.
16. Barker JN, MacDonald D. Eruptive dysplastic naevi following renal transplantation. Clin Exp Dermatol. 1988;13(2):123-125.
17. Woodhouse J, Maytin E. Eruptive nevi of the palms and soles. J Am Acad Dermatol. 2005;52(5)(suppl 1):S96-S100.
18. Belloni Fortina A, Piaserico S, Zattra E, Alaibac M. Dermoscopic features of eruptive melanocytic naevi in an adult patient receiving immunosuppressive therapy for Crohn's disease. Melanoma Res. 2005;15(3):223-224.
19. Bovenschen HJ, Tijoe M, Vermaat H, et al. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. Br J Dermatol. 2006;154(5):880-886.
20. Hughes BR, Cunliffe W, Bailey C. Excess benign melanocytic naevi in children after chemotherapy for malignancy in childhood. BMJ. 1989;299(6691):88-91.
21. Ibsen HH, Clemmensen O. Eruptive nevi in Addison's disease. Arch Dermatol. 1990;126(9):1239-1240.
22. Cruz A, Sanchez J. Acral PUVA-induced pigmented macules. Bol Asoc Med P R. 1990;82(10):460-462.
23. Coskey R. Eruptive nevi [letter]. Arch Dermatol. 1975;111(12):1658.
24. Eady RA, Gilkes J, Jones E. Eruptive naevi: report of two cases, with enzyme histochemical, light and electron microscopical findings. Br J Dermatol. 1977;97(3):267-278.
25. Grob JJ, Bastuji-Garin S, Vaillant L, et al. Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant recipients. J Invest Dermatol. 1996;107(5):694-697.
26. Ross PM. Apparent absence of a benign precursor lesion: implications for the pathogenesis of malignant melanoma. J Am Acad Dermatol. 1989;21(3 pt 1):529-538.
27. Alaibac M, Piaserico S, Rossi C, et al. Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings. J Am Acad Dermatol. 2003;49(6):1020-1022.
28. Berg D, Otley C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47(1):1-17.
29. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F. Melanomas in renal transplant recipients. Br J Dermatol. 2006;154(3):472-477.